TipRanks
Khiron Life Sciences Corp (KHRNF)
OTHER OTC:KHRNF
US Market

Khiron Life Sciences (KHRNF) Ratios

172 Followers

Khiron Life Sciences Ratios

KHRNF's free cash flow for Q3 2022 was C$―. For the 2022 fiscal year, KHRNF's free cash flow was decreased by C$ and operating cash flow was C$―. See a summary of the company’s cash flow.
Ratios
TTM
Mar 22Mar 21Mar 20Mar 19
Liquidity Ratios
Current Ratio
3.08-- ― ―
Quick Ratio
1.86-- ― ―
Cash Ratio
1.16-- ― ―
Solvency Ratio
-3.83-- ― ―
Operating Cash Flow Ratio
-2.70-- ― ―
Short-Term Operating Cash Flow Coverage
-13.71-- ― ―
Net Current Asset Value
C$ 14.83MC$ 14.83MC$ 26.46MC$ ―C$ ―
Leverage Ratios
Debt-to-Assets Ratio
0.05-- ― ―
Debt-to-Equity Ratio
0.07-- ― ―
Debt-to-Capital Ratio
0.06-- ― ―
Long-Term Debt-to-Capital Ratio
0.02-- ― ―
Financial Leverage Ratio
1.27-- ― ―
Debt Service Coverage Ratio
-10.55-- ― ―
Interest Coverage Ratio
-50.18-- ― ―
Debt to Market Cap
0.24-- ― ―
Interest Debt Per Share
0.02-- ― ―
Net Debt to EBITDA
0.32 0.21 0.83 ― ―
Profitability Margins
Gross Profit Margin
22.47%--――
EBIT Margin
-275.47%--――
EBITDA Margin
-165.81%--――
Operating Profit Margin
-174.52%--――
Pretax Profit Margin
-262.56%--――
Net Profit Margin
-258.92%--――
Continuous Operations Profit Margin
-258.92%--――
Net Income Per EBT
98.62%--――
EBT Per EBIT
150.44%--――
Return on Assets (ROA)
-78.37%-78.37%-32.85%――
Return on Equity (ROE)
-68.62%-99.40%-38.02%――
Return on Capital Employed (ROCE)
-64.62%-57.26%-35.85%――
Return on Invested Capital (ROIC)
-61.04%-54.08%-35.28%――
Return on Tangible Assets
-99.62%-88.74%-44.57%――
Earnings Yield
-503.43%-96.55%-52.89%――
Efficiency Ratios
Receivables Turnover
4.44-- ― ―
Payables Turnover
2.30-- ― ―
Inventory Turnover
1.05-- ― ―
Fixed Asset Turnover
0.94-- ― ―
Asset Turnover
0.30-- ― ―
Working Capital Turnover Ratio
0.57-- ― ―
Cash Conversion Cycle
271.50 374.54 958.76 ― ―
Days of Sales Outstanding
82.16 82.16 208.66 ― ―
Days of Inventory Outstanding
347.85 537.16 3.02K ― ―
Days of Payables Outstanding
158.51 244.77 2.27K ― ―
Operating Cycle
430.01 619.32 3.23K ― ―
Cash Flow Ratios
Operating Cash Flow Per Share
-0.13-- ― ―
Free Cash Flow Per Share
-0.14-- ― ―
CapEx Per Share
0.01-- ― ―
Free Cash Flow to Operating Cash Flow
1.08-- ― ―
Dividend Paid and CapEx Coverage Ratio
-11.96-- ― ―
Capital Expenditure Coverage Ratio
-11.96-- ― ―
Operating Cash Flow Coverage Ratio
-9.37-- ― ―
Operating Cash Flow to Sales Ratio
-1.63-- ― ―
Free Cash Flow Yield
-243.20%-64.53%-59.90%――
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.20-- ― ―
Price-to-Sales (P/S) Ratio
0.73-- ― ―
Price-to-Book (P/B) Ratio
0.20-- ― ―
Price-to-Free Cash Flow (P/FCF) Ratio
-0.41-- ― ―
Price-to-Operating Cash Flow Ratio
-0.32-- ― ―
Price-to-Earnings Growth (PEG) Ratio
>-0.01-- ― ―
Price-to-Fair Value
0.20-- ― ―
Enterprise Value Multiple
-0.12-- ― ―
Enterprise Value
2.60M 27.62M 26.59M ― ―
EV to EBITDA
-0.12 -0.86 -1.16 ― ―
EV to Sales
0.20 2.16 3.32 ― ―
EV to Free Cash Flow
-0.12 -1.25 -0.98 ― ―
EV to Operating Cash Flow
-0.12 -1.35 -1.08 ― ―
Tangible Book Value Per Share
0.15-- ― ―
Shareholders’ Equity Per Share
0.20-- ― ―
Tax and Other Ratios
Effective Tax Rate
0.01-- ― ―
Revenue Per Share
0.08-- ― ―
Net Income Per Share
-0.20-- ― ―
Tax Burden
0.99 0.99 1.00 ― ―
Interest Burden
0.95 1.01 1.02 ― ―
Research & Development to Revenue
0.10 0.10 0.19 ― ―
SG&A to Revenue
1.87 1.67 3.23 ― ―
Stock-Based Compensation to Revenue
0.18 0.18 0.71 ― ―
Income Quality
0.63 0.61 1.02 ― ―
Currency in CAD